EFAVIRENZ
Generic: EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Teva Pharmaceuticals USAManufacturer
ORALRoute
EFAVIRENZActive Substance
2018-11-09Original Approval
EFAVIRENZ is FDA application ANDA091215, sponsored by TEVA PHARMS USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FOETAL EXPOSURE DURING PREGNANCY
48 reports
2
EXPOSURE DURING PREGNANCY
36 reports
3
MATERNAL EXPOSURE DURING PREGNANCY
22 reports
4
ABORTION SPONTANEOUS
21 reports
5
DRUG EXPOSURE DURING PREGNANCY
14 reports
6
ANAEMIA
13 reports
7
DRUG INTERACTION
13 reports
8
PYREXIA
12 reports
9
VOMITING
12 reports
10
DIARRHOEA
11 reports